Showing results (1321-1330 of 2,709) with videos related to
Sort By:
Pageof 271
The Lancet. Infectious Diseases|December 15, 2022
Effects of social norm feedback on antibiotic prescribing and its characteristics in behaviour change techniques: a mixed-methods systematic reviewYingchao Zeng, Lin Shi, Chaojie Liu, et al.The Lancet. Infectious Diseases|June 3, 2004
Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosisMonique A S H Mennink-Kersten, J Peter Donnelly, Paul E VerweijThe Lancet. Infectious Diseases|April 15, 2011
From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreakFrançois Caron, Isabelle Parent du Châtelet, Jean-Philippe Leroy, et al.The Lancet. Infectious Diseases|June 25, 2011
Consequences of HIV infection on malaria and therapeutic implications: a systematic reviewClara Flateau, Guillaume Le Loup, Gilles PialouxThe Lancet. Infectious Diseases|October 30, 2012
Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trialRovina Ruslami, A Rizal Ganiem, Sofiati Dian, et al.The Lancet. Infectious Diseases|July 24, 2012
Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance dataRyan T Novak, Jean Ludovic Kambou, Fabien Vk Diomandé, et al.The Lancet. Infectious Diseases|November 4, 2015
The Ebola Vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threatsMichael Osterholm, Kristine Moore, Julie Ostrowsky, et al.The Lancet. Infectious Diseases|July 1, 2026
Community-based tuberculosis screening with computer-aided detection technology alone and in combination with point-of-care C-reactive protein testing: a paired screen-positive trialKlaus Reither, Fiona Vanobberghen, Anna Verjans, et al.The Lancet. Infectious Diseases|June 30, 2026
Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trialHong-Xing Pan, Zhao-Feng Bi, Yu-Lin Jing, et al.Pageof 271